CARGO Therapeutics | IPO Presentation Deck | 29 slides

CARGO Therapeutics · 2024-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
summarize
04
front_matter
Open slide detailLoop · Golden Circle
05
The slide uses a chevron-based layout to categorize key company pillars.summarize
Open slide detailLoop · Golden Circle
06
other
Open slide detailBeat · TeamLoop · Golden Circle
07
The slide is split into two sections: individual board member profiles and a grid of investor logos.other
Open slide detailBeat · TeamLoop · Golden Circle
08
The chart uses a Gantt-style visualization to represent clinical trial phases for different indications.plan_implementation
Open slide detailLoop · Golden Circle
09
size_opportunity
Open slide detailBeat · Market SizeLoop · Golden Circle
10
The slide uses a Kaplan-Meier curve to visually demonstrate the 'problem' (rapid progression) and a callout box to quantify the market opportunity.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
11
The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.transition
Open slide detailLoop · Cost Of Inaction
12
Includes Kaplan-Meier survival curves and a summary table of clinical outcomes.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
13
The slide uses a process flow diagram to illustrate the clinical trial stages.present_framework
Open slide detailBeat · TractionLoop · Cost Of Inaction
14
The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.compare_peers
Open slide detailBeat · TractionLoop · Cost Of Inaction
15
Kaplan-Meier survival curve shown.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
16
The slide outlines the methodology for a clinical trial, specifically detailing the patient population and treatment protocol.present_framework
Open slide detailLoop · Golden Circle
17
The table uses checkmarks to indicate which strategic principles impact specific operational metrics.present_framework
Open slide detailLoop · Golden Circle
18
The slide uses a biological schematic to explain the mechanism of action and key design features of the therapeutic candidate.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
19
Features a stylized 3D rendering of a cell, likely representing CAR-T or similar cellular therapy.transition
Open slide detailLoop · Golden Circle
20
The slide uses a problem-solution mapping framework to explain the therapeutic approach.present_solution
Open slide detailLoop · Golden Circle
21
The slide uses a biological mechanism diagram, a Kaplan-Meier survival curve, and IHC images to demonstrate the clinical impact of CD58 loss.frame_problem
Open slide detailLoop · Golden Circle
22
transition
Open slide detailLoop · Golden Circle
23
The slide uses a funnel diagram to represent the screening process and bar charts to demonstrate specificity across CD19, CD20, and CD22 targets.present_solution
Open slide detailLoop · Golden Circle
24
Data shows bioluminescent flux over time; CRG-023 consistently reduces tumor burden to baseline.show_traction
Open slide detailLoop · Golden Circle
25
transition
Open slide detailLoop · Golden Circle
26
The slide uses a matrix structure to categorize therapies by modality and development stage, highlighting CARGO's specific positioning.compare_peers
Open slide detailLoop · Golden Circle
27
transition
Open slide detailLoop · Golden Circle
28
Includes investor logos, financial metrics, and a timeline of clinical milestones.summarize
Open slide detailLoop · Golden Circle
29
summarize